Metraipolis › archive › dc_4574bcb69715
Analysis of adverse drug reactions associated with ravulizumab: a retrospective pharmacovigilance study utilizing the FAERS database — Europe PMC PMID:41822500
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41822500
- DOI
- 10.3389/fimmu.2026.1736692
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T12:34:59.137Z
- SHA-256 of the archived text
11642f7f9f27a0030a1f42030b9c0539c46389f0c0ff0fe9da3d3473eaaf08ed- Stable URL of this page
https://metraipolis.com/documento/dc_4574bcb69715
How to cite
Analysis of adverse drug reactions associated with ravulizumab: a retrospective pharmacovigilance study utilizing the FAERS database — Europe PMC PMID:41822500 — Europe PMC (en), https://europepmc.org/article/MED/41822500 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4574bcb69715 (Metraipolis archive dc_4574bcb69715, sha256 11642f7f9f27a0030a1f42030b9c0539c46389f0c0ff0fe9da3d3473eaaf08ed)
BibTeX
@misc{dc4574bcb69715,
title = {Analysis of adverse drug reactions associated with ravulizumab: a retrospective pharmacovigilance study utilizing the FAERS database — Europe PMC PMID:41822500},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41822500},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4574bcb69715; sha256 11642f7f9f27a0030a1f42030b9c0539c46389f0c0ff0fe9da3d3473eaaf08ed},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41822500. Agents can read the archived copy with the MCP tool read_document.